Annual EBIT
-$15.35 M
+$12.30 M+44.49%
31 December 2023
Summary:
Aileron Therapeutics annual earnings before interest & taxes is currently -$15.35 million, with the most recent change of +$12.30 million (+44.49%) on 31 December 2023. During the last 3 years, it has risen by +$5.15 million (+25.12%). ALRN annual EBIT is now -19.06% below its all-time high of -$12.57 million.ALRN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$6.07 M
+$2.97 M+32.84%
30 September 2024
Summary:
Aileron Therapeutics quarterly earnings before interest & taxes is currently -$6.07 million, with the most recent change of +$2.97 million (+32.84%) on 30 September 2024. Over the past year, it has dropped by -$4.09 million (-207.08%). ALRN quarterly EBIT is now -207.08% below its all-time high of -$1.98 million, reached on 30 September 2023.ALRN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$29.62 M
-$4.09 M-16.04%
30 September 2024
Summary:
Aileron Therapeutics TTM earnings before interest & taxes is currently -$29.62 million, with the most recent change of -$4.09 million (-16.04%) on 30 September 2024. Over the past year, it has dropped by -$16.87 million (-132.31%). ALRN TTM EBIT is now -651.89% below its all-time high of -$3.94 million, reached on 31 March 2016.ALRN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.5% | -207.1% | -132.3% |
| 3 y3 years | +25.1% | +10.6% | -23.5% |
| 5 y5 years | +51.9% | +23.3% | -0.1% |
ALRN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +44.5% | -207.1% | +32.8% | -132.3% | +1.5% |
| 5 y | 5 years | at high | +51.9% | -207.1% | +32.8% | -132.3% | +1.5% |
| alltime | all time | -19.1% | +51.9% | -207.1% | +37.1% | -651.9% | +7.3% |
Aileron Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.07 M(-32.8%) | -$29.62 M(+16.0%) |
| June 2024 | - | -$9.04 M(+25.5%) | -$25.52 M(+37.5%) |
| Mar 2024 | - | -$7.21 M(-1.3%) | -$18.56 M(+21.0%) |
| Dec 2023 | -$15.35 M(-44.5%) | -$7.30 M(+269.3%) | -$15.35 M(+20.4%) |
| Sept 2023 | - | -$1.98 M(-5.0%) | -$12.75 M(-26.1%) |
| June 2023 | - | -$2.08 M(-47.9%) | -$17.25 M(-25.7%) |
| Mar 2023 | - | -$3.99 M(-15.2%) | -$23.21 M(-16.0%) |
| Dec 2022 | -$27.65 M(+3.9%) | -$4.70 M(-27.4%) | -$27.65 M(-7.1%) |
| Sept 2022 | - | -$6.48 M(-19.4%) | -$29.76 M(-1.0%) |
| June 2022 | - | -$8.04 M(-4.5%) | -$30.07 M(+7.2%) |
| Mar 2022 | - | -$8.42 M(+23.5%) | -$28.04 M(+5.4%) |
| Dec 2021 | -$26.61 M(+29.8%) | -$6.82 M(+0.4%) | -$26.61 M(+10.9%) |
| Sept 2021 | - | -$6.79 M(+13.0%) | -$23.98 M(+7.9%) |
| June 2021 | - | -$6.01 M(-14.0%) | -$22.22 M(+7.8%) |
| Mar 2021 | - | -$6.99 M(+66.7%) | -$20.61 M(+0.6%) |
| Dec 2020 | -$20.50 M | -$4.19 M(-16.6%) | -$20.50 M(-13.3%) |
| Sept 2020 | - | -$5.03 M(+14.3%) | -$23.65 M(-10.9%) |
| June 2020 | - | -$4.40 M(-36.0%) | -$26.54 M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$6.88 M(-6.4%) | -$29.52 M(-1.5%) |
| Dec 2019 | -$29.96 M(-6.1%) | -$7.35 M(-7.2%) | -$29.96 M(+1.2%) |
| Sept 2019 | - | -$7.92 M(+7.3%) | -$29.59 M(+1.4%) |
| June 2019 | - | -$7.38 M(+0.9%) | -$29.17 M(-7.2%) |
| Mar 2019 | - | -$7.31 M(+4.7%) | -$31.45 M(-1.4%) |
| Dec 2018 | -$31.90 M(+38.7%) | -$6.98 M(-6.9%) | -$31.90 M(-0.2%) |
| Sept 2018 | - | -$7.50 M(-22.4%) | -$31.96 M(+3.5%) |
| June 2018 | - | -$9.66 M(+24.4%) | -$30.89 M(+18.0%) |
| Mar 2018 | - | -$7.76 M(+10.3%) | -$26.18 M(+13.8%) |
| Dec 2017 | -$23.01 M(+26.6%) | -$7.04 M(+9.6%) | -$23.01 M(+12.7%) |
| Sept 2017 | - | -$6.43 M(+29.8%) | -$20.41 M(+12.0%) |
| June 2017 | - | -$4.95 M(+7.9%) | -$18.22 M(-3.2%) |
| Mar 2017 | - | -$4.59 M(+3.2%) | -$18.82 M(+3.6%) |
| Dec 2016 | -$18.17 M(+40.9%) | -$4.45 M(+5.1%) | -$18.17 M(+32.4%) |
| Sept 2016 | - | -$4.23 M(-23.7%) | -$13.72 M(+44.6%) |
| June 2016 | - | -$5.55 M(+40.9%) | -$9.49 M(+140.9%) |
| Mar 2016 | - | -$3.94 M | -$3.94 M |
| Dec 2015 | -$12.89 M | - | - |
FAQ
- What is Aileron Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aileron Therapeutics?
- What is Aileron Therapeutics annual EBIT year-on-year change?
- What is Aileron Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly EBIT year-on-year change?
- What is Aileron Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aileron Therapeutics?
- What is Aileron Therapeutics TTM EBIT year-on-year change?
What is Aileron Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ALRN is -$15.35 M
What is the all time high annual EBIT for Aileron Therapeutics?
Aileron Therapeutics all-time high annual earnings before interest & taxes is -$12.57 M
What is Aileron Therapeutics annual EBIT year-on-year change?
Over the past year, ALRN annual earnings before interest & taxes has changed by +$12.30 M (+44.49%)
What is Aileron Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ALRN is -$6.07 M
What is the all time high quarterly EBIT for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly earnings before interest & taxes is -$1.98 M
What is Aileron Therapeutics quarterly EBIT year-on-year change?
Over the past year, ALRN quarterly earnings before interest & taxes has changed by -$4.09 M (-207.08%)
What is Aileron Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ALRN is -$29.62 M
What is the all time high TTM EBIT for Aileron Therapeutics?
Aileron Therapeutics all-time high TTM earnings before interest & taxes is -$3.94 M
What is Aileron Therapeutics TTM EBIT year-on-year change?
Over the past year, ALRN TTM earnings before interest & taxes has changed by -$16.87 M (-132.31%)